Difference between revisions of "Team:Heidelberg/project/hlpd"

To create these constructs, we relied on the capabilities of our JAWS software. This enables us to select a small pool of possible stem candidates that might show the required switching behavior. Yet to really prove the performance the generated stems has to be analyzed.

For switching, stem has to be in similar range of formation energy to the strong gros2005hemin-G-quadruplex-complex to enable an equilibrium state. This equilibrium is creating a bistable system so it can be shifted by the binding of the ligand to the aptamer. Yet if the stem is rather weak the amount of active G-quadruplexes, which have been formed without the binding of any ligand molecules, increases. Yet if the stem is getting stronger than the energy gained from ligand binding, the amount of switching DNAzymes decreases. The other important variable contributing to the behavior of the switching DNAzyme is the affinity of the aptamer. This is described by the K_D value. As we want to characterize the aptamers generated by the MAWS software the best way possible, we want to guess this parameter from the data we record during this screening effort with our modelling approach.

To obtain this necessary data we had to record the enzyme activity of a DNAzyme candidate at multiple ligand concentration levels. To do so we chose to record the halflives of the chemiluminescent substrate luminol. With the assumption of first order kinetics the half-life of the luminol signal $t_{1/2}=\frac{ln2}{ k_{act}*c_{active DNAzyme}}$ is inversely proportional to the enzyme activity $k_{act}*c_{active DNAzyme}$.
Thereby we can perform the necessary modelling to obtain the K_D.

Methods

To perform this screening with the necessary throughput to validate numerous aptamer and DNAzyme candidates generated by the software with the necessary precision, we resorted to a robot aided screening in 96well plates. The Hamilton Microlab Star Liquid Handling robot provided us with the necessary dilution series of the target ligand in 96well plates. After addition of the 1µM DNAzyme/hemin mix a western blotting luminol substrate was dispensed to all wells at a specified time point. To record a time series on luminol luminescence for every well without a timing bias of sequential scanning, we chose to scan all wells of the plates simultaneously with a western blot documentation camera in repetitive capture mode.

Fig. 3: Aptamer high-throughput screening workflow.

The recorded sequences were segmented by automated ImageJ masks to obtain the mean intensity for each well at all time points. The data was loaded into MATLAB for further processing. By exponential fitting of the datapoints the halflives were obtained. Plotting those against the concentration gives good indication on the switching behavior of a certain candidate.

First we can confirm the capability of our system to provide reasonable data and for example show that the activity of the HRP-mimicking DNAzyme is independent from the concentration of the screened Kanamycin ligand. Secondly we can show that some candidates show the expected switching behavior while others suggest with their plateau trajectory, that the screened stem candidate does not seem to stabilize a bistable conformation.

Fig. 4: Screening of Kanamycin Aptamer candidates.

All recorded halfvalues for Kanamycin aptamer candidates with different stem variants plotted against kanamycin ligand concentrations ranging from 0µM to 1920µM. For all software generated aptamer candidates stem candidates with switching behavior suggesting trajectosies can be identified. Buffer shows no clear half values but camera noise.

Fig. 5: Selected trajectories from the Kanamycin aptamer screen.

All recorded halfvalues for Kanamycin aptamer candidates with different stem variants plotted against kanamycin ligand concentrations ranging from 0µM to 1920µM. Buffer shows no clear half values but camera noise.

Methods for F8-Setup

We computationally designed a communication module for an HRP-F8 fusion DNAzyme using our software JAWS. Aptamers for ampicillin and ketamine were joined to the stem of the fused F8 DNAzyme to regulate its cleavage activity. The ketamine-binding aptamer was previously designed by our software MAWS to specifically target the anesthetic, while the ampicillin-specific aptamer was previously published Song2012. The fusion DNAzymes were tested against their respective ligand in solution, where 1 µM DNAzyme hemine solution was incubated together with the ligand, hydrogen peroxide, and TMB. Reactions were stopped using 1 mM hydrochloric acid.

Ampicillin-reactive DNAzyme

Figure 6: Ampicillin-responsive HRP-F8 fusion DNAzyme.

A fusion of an ampicillin-binding aptamer and the HRP-F8 DNAzyme was incubated with hydrogen peroxide and TMP in either the presence or absence of ampicillin in A) reaction buffer or B) ampicillin-spiked energy drink.

Ketamine-reactive DNAzyme

Figure 7: Ketamine-responsive HRP-F8 fusion DNAzyme.

Fusions of a ketamine-binding aptamer and the HRP-F8 fusion DNAzyme designed to switch either on or off in the presence of ketamine as well as negative controls (DNAzymes predicted by our software to not possess an efficient switching behavior) were incubated with hydrogen peroxide and TMP in either the presence or absence of ketamine.

Catalytic activity of the ampicillin-responsive DNAzyme drastically increased upon exposure to its ligand (Fig. 1A), indicated by the solution turning deep blue, while the negative control lacking ampicillin was only faintly coloured. To test this detection system in a more realistic setting, the DNAzyme was incubated in energy drink spiked with ampicillin. Here, a fainter change in color, presumably due to suboptimal buffer conditions was observed, with the ampicillin-spiked beverage still showing significant discoloration compared to the pure drink (Fig. 1B). From the two DNAzymes designed for ketamine one switched on in the presence of ketamine, while the other switched off. Both produced similar colors after the reaction was stopped (Fig 1 A+B). Thus, our software suite proved successfull in designing a detection system for a drug within less than a day of computation.